Chief Science Officer Erick Berglund interviewed on the Price of Business with Kevin Price In the News / By Intrommune
Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report Press Releases / By Intrommune
Global Data publishes profile of Intrommune Therapeutics’ Phase Ib study and its Series B raise In the News / By Intrommune
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301 Press Releases / By Intrommune
William Reisacher, MD’s article in Coping with Allergies & Asthma: Five Things you Should Know about Peanut Allergy Immunotherapy In the News / By Intrommune
Intrommune CEO, Michael Nelson, spoke with PetaCrunch about Intrommune’s approach to treating peanut allergies In the News / By Intrommune
Intrommune selected as Semifinalist in the Innovate Children’s Health Challenge In the News / By Intrommune
